End-stage Lung Disease

End-stage lung disease represents the advanced stage of chronic respiratory conditions where lung function is severely compromised, leading to significant impairment in oxygenation, ventilation, and overall quality of life. Patients with end-stage lung disease, including advanced chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, or cystic fibrosis, often experience persistent shortness of breath, fatigue, and frequent exacerbations that require intensive management. Care focuses on symptom relief, optimizing remaining lung function, and improving quality of life through a combination of pharmacological, supportive, and palliative interventions. Oxygen therapy, non-invasive or mechanical ventilation, and pharmacologic agents targeting inflammation, infection, or bronchoconstriction are commonly employed, alongside pulmonary rehabilitation to maintain mobility and respiratory muscle strength. End-stage lung disease also emphasizes multidisciplinary collaboration, with pulmonologists, palliative care specialists, respiratory therapists, and nursing staff working together to develop individualized care plans and provide patient and caregiver education. Advanced care planning, psychosocial support, and strategies to manage anxiety and fatigue are critical in addressing both physical and emotional needs. Emerging treatments, including lung transplantation and innovative regenerative therapies, offer potential options for selected patients, highlighting the importance of timely evaluation and referral. By integrating medical management, supportive care, and patient-centered strategies, end-stage lung disease care aims to maintain comfort, enhance functional capacity, and support dignity and quality of life in the final stages of chronic respiratory illness.